The fact that the College Football Playoff quarterfinal round kicks off just before the transfer portal officially opens ...

In recent years, the WNBA Draft has taken place in April shortly after the NCAA Final Four, giving top college players only a ...

The New York Yankees add former Brewers rookie of eight years Ernesto Martinez Jr. as third new first base option, joining ...

While the Phase 3 trial of vilobelimab in ulcerative pyoderma gangrenosum (PG) was terminated earlier this year due to ...

The Tartans have jelled quickly collectively, getting off to a 2-0 start, defeating Central Jersey Charter 71-5 in its season ...

The Edmonton Oilers concluded their five-game road trip and kicked off their weekend back-to-back against the red-hot ...

Investing.com -- Q32 Bio Inc (NASDAQ:QTTB) stock surged 94% in premarket trading Monday after the clinical-stage biotechnology company announced the sale of its Phase 2 complement inhibitor, ADX-097, ...

(RTTNews) - Biotechnology company Q32 Bio, Inc. (QTTB) announced Monday it has sold its Phase 2 complement inhibitor, ADX-097, to Akebia Therapeutics, Inc. (AKBA). ADX-097, the lead product candidate ...

After a busy offseason, the Golden State Warriors have added several new pieces to their roster as they aim for another championship run. With Jonathan Kuminga’s contract situation finally settled, ...

The Coca‑Cola Co., Atlanta, reported second quarter 2025 results. For the quarter, net revenues grew 1% to $12.5 billion, and organic revenues (non-GAAP) grew 5%. Revenue performance included 6% ...